M08.0

⚠ Non-billable (Header)

Unspecified juvenile rheumatoid arthritis

Diseases of the musculoskeletal system and connective tissue (M00-M99)

⚠️ This is a category header code — not billable. Use a more specific child code below.

Check This Code

Also Known As

Juvenile rheumatoid arthritis with or without rheumatoid factor

❌ Excludes1

inherited

Rules inherited from parent codes in the hierarchy.

  • arthropathy in Whipple's disease (M14.8)
  • Felty's syndrome (M05.0)
  • juvenile dermatomyositis (M33.0-)
  • psoriatic juvenile arthropathy (L40.54)

Clinical Description

ICD-10-CM code M08.0 represents unspecified juvenile rheumatoid arthritis. This code falls under the Diseases of the musculoskeletal system and connective tissue (M00-M99) classification. It is a non-billable category header code. A more specific child code from the list below must be used for billing and reimbursement purposes.

This is a 5-character code at the 4th level of specificity. There are 11 more specific child codes under M08.0. Coders should note that M08.0 has 4 Excludes1 restriction(s) — codes that cannot be reported together on the same claim.

Frequently Asked Questions

What is ICD-10 code M08.0?

ICD-10-CM code M08.0 is "Unspecified juvenile rheumatoid arthritis". It belongs to the category: Diseases of the musculoskeletal system and connective tissue (M00-M99).

Is M08.0 a billable ICD-10 code?

No, M08.0 is a non-billable header code. A more specific child code must be used for billing.

What codes are excluded with M08.0?

M08.0 has 4 Excludes1 rule(s). These codes are mutually exclusive and cannot be coded together on the same claim.

🧪 Validate Combinations

Add M08.0 to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeM08.0
BillableNo — Header code
ParentM08
CategoryDiseases of the musculoskeletal system and connective tissue (M00-M99)
Excludes14 rule(s)
Excludes20 note(s)
Child codes11

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)